Understanding and developing responses to emerging infectious diseases
Operations Core
This study at the University of Pittsburgh is all about finding better ways to understand and fight new infectious diseases, so that patients like you can benefit from improved treatments and prevention methods when facing health threats.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10910181 on NIH RePORTER |
What this research studies
This research focuses on the Regional Biocontainment Laboratory at the University of Pittsburgh, which is dedicated to studying emerging infectious diseases and their transmission. The team works on understanding how pathogens evolve and spread, while also developing new medical interventions to prepare for potential pandemics. Patients may benefit from advancements in treatments and preventive measures that arise from this research, as it aims to enhance our ability to respond to biological threats. The research involves collaboration among infection biologists and clinicians who utilize specialized laboratory facilities to conduct their work safely.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk for emerging infectious diseases or those involved in healthcare and public health responses.
Not a fit: Patients with chronic, non-infectious conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel treatments and preventive strategies for infectious diseases that pose a threat to public health.
How similar studies have performed: Previous research in similar biocontainment and infectious disease studies has shown success in developing effective responses to emerging health threats.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Duprex, William Paul — University of Pittsburgh at Pittsburgh
- Study coordinator: Duprex, William Paul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.